Herndon Capital Management’s Allergan plc AGN Stock Holding History

Herndon Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-36	Closed	-$8K	–	587
2016 Q3	$8K	Hold	36	–	–	﹤0.01%	195
2016 Q2	$8K	Buy	+36	New	+$8.3K	﹤0.01%	195
2015 Q3	–	Sell	-210,065	Closed	-$63.7M	–	229
2015 Q2	$63.7M	Buy	+210,065	New	+$62.7M	1.06%	40
2015 Q1	–	Sell	-107	Closed	-$28K	–	223
2014 Q4	$28K	Sell	107 -7,333	-99%	-$1.83M	﹤0.01%	143
2014 Q3	$1.8M	Sell	7,440 -5,664	-43%	-$1.27M	0.02%	92
2014 Q2	$2.92M	Sell	13,104 -720	-5%	-$149K	0.04%	85
2014 Q1	$2.85M	Sell	13,824 -3,484	-20%	-$690K	0.04%	79
2013 Q4	$2.91M	Sell	17,308 -5,289	-23%	-$827K	0.04%	85
2013 Q3	$3.25M	Buy	22,597 +206	+0.9%	+$27.4K	0.04%	79
2013 Q2	$2.83M	Buy	+22,391	New	+$2.54M	0.04%	85

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Herndon Capital Management's AGN Position: Q4 2016 in Review

Herndon Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 36 shares — an estimated $8K sold.

Herndon Capital Management first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $63.7M in Q2 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

Herndon Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
Herndon Capital Management sold 36 Allergan plc shares in Q4 2016, an estimated $8K.
Herndon Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
Herndon Capital Management's Allergan plc position peaked at $63.7M in Q2 2015.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Herndon Capital Management's 13F filing for Q4 2016, filed 2 Feb 2017.